Cargando…
妊娠期停用酪氨酸激酶抑制剂对慢性髓性白血病患者疾病状态及生育结果影响的观察
OBJECTIVE: To explore the pregnancy outcome and disease status among patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitor (TKI) when they stopped TKI treatment during pregnancy. METHODS: The clinical characteristics, reproductive outcomes and disease status of the pati...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342204/ https://www.ncbi.nlm.nih.gov/pubmed/30122011 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.07.003 |
Ejemplares similares
-
中国真实世界慢性髓性白血病患者停用酪氨酸激酶抑制剂的观察研究
Publicado: (2022) -
中国服用酪氨酸激酶抑制剂的慢性髓性白血病慢性期患者共存疾病状况及其对患者报告结果的影响
Publicado: (2018) -
慢性髓性白血病酪氨酸激酶抑制剂治疗后出现Ph(−)细胞染色体异常八例临床观察
Publicado: (2016) -
儿童慢性髓性白血病酪氨酸激酶抑制剂停药的研究进展
Publicado: (2023) -
BCR-ABL激酶区突变在酪氨酸激酶抑制剂耐药慢性髓性白血病患者中的分布及其影响因素
Publicado: (2020)